Grifols SA ADR (GRFS)

Grifols SA ADR (GRFS) is a Drug Manufacturers - General company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.2B; returns 1 day +1.5%, 1 week -1.0%, 1 year -20.8%.

Grifols SA is a global healthcare company specializing in the production of plasma-derived medicines. The company operates on a vertically integrated business model, controlling the entire process from plasma collection via its extensive network of over 400 donor centers to the manufacturing and distribution of final products.

Groups GRFS belongs to

• Healthcare
• Biotechnology
• Plasma Collection
• Biopharmaceutical
• Biologics
• Vertical Integration
• Pharmaceuticals
• Immunotherapy
• Life Sciences
• Commercial Stage

GRFS financial model: income statement, cash flow and balance sheet